Role of a novel oncogene in mesothelioma
Role of a novel oncogene in mesothelioma
批准号:
6897553
负责人:
ALICE M BOYLAN
金额:
$24.27万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-01 至 2008-05-31
关键词:
3T3 cellsRNase protection assaySCID mouseactinomycinasbestoscell cycle proteinscell proliferationchemical related neoplasm /cancerclinical researchfree radical oxygenfunctional /structural genomicsgene expressiongene induction /repressiongenetically modified animalshuman subjectmesotheliomaneoplasm /cancer geneticsoncogenesphenotypetransfection /expression vector
中文摘要
描述(由申请人提供):在美国,每年新诊断的职业性恶性间皮瘤高达3,000人,其中大多数患者将在诊断后12个月内死亡,无论治疗如何。在美国,数百万人仍处于危险之中,而在发展中国家,石棉仍在使用,而且往往没有保护措施,预计处于危险之中的人数将攀升。为了显着影响这种疾病更多的需要知道的分子机制所需的启动和维持恶性状态的间皮细胞。虽然一些研究人员已经描述了间皮瘤细胞中某些基因表达的增加,但没有癌基因被证明具有功能重要性。这项工作的初步研究表明,一个独特的癌基因命名为CaSm,这是可能通过其在RNA信息不稳定的作用转化细胞,具有高水平的表达信息和蛋白质在几乎所有间皮瘤细胞系和大多数间皮瘤肿瘤检查。进一步的初步研究表明,反义CaSm抑制间皮瘤细胞在体外和体内的生长。反义CaSm抑制生长与细胞特异性细胞周期改变和特异性细胞周期相关蛋白表达增加有关。从这项工作中,我们形成了这样的假设:升高的CaSm表达在石棉诱导的恶性间皮瘤的恶性表型的发展和维持中起着至关重要的作用。为了确定CaSm表达在间皮瘤细胞的恶性表型中的作用,将使用正义和反义策略以及小的抑制性RNA进行一系列功能丧失和功能获得实验。还将通过开发以组织特异性方式条件性表达CaSm的转基因小鼠在体内进行重要的功能获得实验。重点将放在CaSm在细胞周期蛋白表达调控中的作用。然后进行放线菌素追踪和突变分析实验,以确定CaSm是否通过使这些蛋白质的信息不稳定而对细胞周期产生影响。最后,实验将确定石棉是否特异性地诱导CaSm的表达,以及它是否通过活性氧或通过其他已知的机制,如整合素粘附。我们相信这些研究将为这种癌症提供令人兴奋的信息和重要的见解。
英文摘要
DESCRIPTION (provided by applicant): The occupational cancer malignant mesothelioma is newly diagnosed in up to 3,000 persons per year in the US and most of these patients will die within 12 months of diagnosis regardless of treatment. Millions remain at risk in the US and the number at risk is expected to climb in developing nations where asbestos continues to be used, often without protection. In order to significantly impact this disease more needs to be known about the molecular mechanisms required for the initiation and maintenance of the malignant state in the mesothelial cell. Although a number of investigators have described increases in expression of some genes in mesothelioma cells, no oncogenes have been shown to have functional importance. Studies preliminary to this work show that a unique oncogene named CaSm, which is likely to transform cells through its role in RNA message destabilization, has high levels of expression of message and protein in virtually all mesothelioma cell lines and the majority of mesothelioma tumors examined. Further preliminary studies show that antisense CaSm inhibits growth of mesothelioma cells in vitro and in vivo. Antisense CaSm inhibition of growth is associated with cell-specific cell cycle alterations and increased expression of specific cell cycle-associated proteins. From this work we formed the hypothesis that: elevated CaSm expression plays a critical role in the development and maintenance of the malignant phenotype in asbestos-induced malignant mesothelioma To establish the role of CaSm expression in the malignant phenotype of mesothelioma cells, a series of loss of function and gain of function experiments will be performed using sense and antisense strategies, as well as small inhibitory RNAs. Important gain of function experiments will also be performed in vivo through the development of a transgenic mouse which will conditionally express CaSm in a tissue-specific manner. Focus will be placed upon the role of CaSm in regulation of expression of cell cycle proteins. Actinomycin chase and mutation analysis experiments will then be performed to determine if CaSm exerts its effect on cell cycle by destabilizing messages for these proteins. Finally experiments will determine whether asbestos specifically induces the expression of CaSm, and if it does so via reactive oxygen species or via other known mechanisms such as integrin adhesion. We believe these studies will provide exciting information and important insight into this cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of a novel oncogene in mesothelioma
-
批准号:7072741
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2003
-
负责人:ALICE M BOYLAN
-
依托单位:
Role of a novel oncogene in mesothelioma
-
批准号:6798291
-
项目类别:
-
资助金额:$24.27万
-
财政年份:2003
-
负责人:ALICE M BOYLAN
-
依托单位:
Role of a novel oncogene in mesothelioma
-
批准号:7231384
-
项目类别:
-
资助金额:$23.01万
-
财政年份:2003
-
负责人:ALICE M BOYLAN
-
依托单位:
A novel oncogene in mesothelioma
-
批准号:6684456
-
项目类别:
-
资助金额:$24.27万
-
财政年份:2003
-
负责人:ALICE M BOYLAN
-
依托单位:
MOLECULAR MARKERS OF PLEURAL INVOLVEMENT--RESECTED NSCLC
-
批准号:2841605
-
项目类别:
-
资助金额:$14.12万
-
财政年份:1999
-
负责人:ALICE M BOYLAN
-
依托单位:
MOLECULAR MARKERS OF PLEURAL INVOLVEMENT--RESECTED NSCLC
-
批准号:6174168
-
项目类别:
-
资助金额:$12.39万
-
财政年份:1999
-
负责人:ALICE M BOYLAN
-
依托单位:
ASBESTOS AND MESOTHELIAL CELL INTERACTIONS
-
批准号:2152937
-
项目类别:
-
资助金额:$5.17万
-
财政年份:1992
-
负责人:ALICE M BOYLAN
-
依托单位:
MOLECULAR MECH. OF ASBESTOS & MESOTHELIAL CELL INTERACT.
-
批准号:3081230
-
项目类别:
-
资助金额:$7.34万
-
财政年份:1992
-
负责人:ALICE M BOYLAN
-
依托单位:
MOLECULAR MECH. OF ASBESTOS & MESOTHELIAL CELL INTERACT.
-
批准号:3081229
-
项目类别:
-
资助金额:$7.34万
-
财政年份:1992
-
负责人:ALICE M BOYLAN
-
依托单位:
ASBESTOS AND MESOTHELIAL CELL INTERACTIONS
-
批准号:2152936
-
项目类别:
-
资助金额:$0.54万
-
财政年份:1992
-
负责人:ALICE M BOYLAN
-
依托单位:
ASBESTOS AND MESOTHELIAL CELL INTERACTIONS
-
批准号:2152938
-
项目类别:
-
资助金额:$4.99万
-
财政年份:1992
-
负责人:ALICE M BOYLAN
-
依托单位:
ASBESTOS AND MESOTHELIAL CELL INTERACTIONS
-
批准号:2152935
-
项目类别:
-
资助金额:$7.34万
-
财政年份:1992
-
负责人:ALICE M BOYLAN
-
依托单位:
PLEURAL INFLAMMATION PROJECT
-
批准号:3051537
-
项目类别:
-
资助金额:$3.38万
-
财政年份:1991
-
负责人:ALICE M BOYLAN
-
依托单位:
PLEURAL INFLAMMATION PROJECT
-
批准号:3051536
-
项目类别:
-
资助金额:$3.18万
-
财政年份:1991
-
负责人:ALICE M BOYLAN
-
依托单位:
海外基金